Cross Country Healthcare, Inc. (CCRN)
USD 14.13
(-0.91%)
USD 14.13
(-0.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 112.71 Million USD | -57.12% |
| 2022 | 273.1 Million USD | 96.05% |
| 2021 | 139.3 Million USD | 772.18% |
| 2020 | 15.97 Million USD | 98.58% |
| 2019 | 8.04 Million USD | 162.45% |
| 2018 | -12.88 Million USD | -209.64% |
| 2017 | 11.74 Million USD | 89.97% |
| 2016 | 6.18 Million USD | -69.93% |
| 2015 | 20.56 Million USD | 296.46% |
| 2014 | -10.46 Million USD | -30.49% |
| 2013 | -8.02 Million USD | 67.28% |
| 2012 | -24.51 Million USD | -332.6% |
| 2011 | 10.54 Million USD | 2703.46% |
| 2010 | 376 Thousand USD | -97.88% |
| 2009 | 17.7 Million USD | 108.85% |
| 2008 | -200.07 Million USD | -576.15% |
| 2007 | 42.01 Million USD | 49.13% |
| 2006 | 28.17 Million USD | -5.23% |
| 2005 | 29.73 Million USD | -18.68% |
| 2004 | 36.56 Million USD | -23.8% |
| 2003 | 47.98 Million USD | -18.22% |
| 2002 | 58.67 Million USD | 52.6% |
| 2001 | 38.44 Million USD | 33.4% |
| 2000 | 28.82 Million USD | 63.26% |
| 1999 | 17.65 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -13.03 Million USD | -260.61% |
| 2024 Q1 | 8.11 Million USD | -39.56% |
| 2023 Q4 | 13.42 Million USD | -33.88% |
| 2023 Q3 | 20.3 Million USD | -42.3% |
| 2023 FY | 117.11 Million USD | -57.12% |
| 2023 Q2 | 35.18 Million USD | -19.65% |
| 2023 Q1 | 43.79 Million USD | -14.9% |
| 2022 Q2 | 78.83 Million USD | -13.01% |
| 2022 FY | 273.1 Million USD | 96.05% |
| 2022 Q4 | 51.46 Million USD | -1.36% |
| 2022 Q3 | 52.17 Million USD | -33.82% |
| 2022 Q1 | 90.63 Million USD | 19.31% |
| 2021 Q2 | 15.9 Million USD | -24.26% |
| 2021 Q1 | 20.99 Million USD | 270.72% |
| 2021 FY | 139.3 Million USD | 772.18% |
| 2021 Q4 | 75.96 Million USD | 187.22% |
| 2021 Q3 | 26.44 Million USD | 66.32% |
| 2020 Q3 | -381 Thousand USD | 97.22% |
| 2020 Q2 | -13.68 Million USD | -1715.38% |
| 2020 FY | 15.97 Million USD | 98.58% |
| 2020 Q4 | 5.66 Million USD | 1586.35% |
| 2020 Q1 | -754 Thousand USD | -138.59% |
| 2019 FY | 8.04 Million USD | 162.45% |
| 2019 Q2 | -15.09 Million USD | -461.61% |
| 2019 Q3 | 119 Thousand USD | 100.79% |
| 2019 Q4 | 1.95 Million USD | 1542.02% |
| 2019 Q1 | -2.68 Million USD | 88.85% |
| 2018 Q3 | 2.64 Million USD | -39.08% |
| 2018 Q2 | 4.34 Million USD | 2.21% |
| 2018 FY | -12.88 Million USD | -209.64% |
| 2018 Q1 | 4.24 Million USD | 167.18% |
| 2018 Q4 | -24.11 Million USD | -1011.72% |
| 2017 Q1 | 3.25 Million USD | -62.61% |
| 2017 Q2 | 6.44 Million USD | 98.13% |
| 2017 FY | 11.74 Million USD | 89.97% |
| 2017 Q3 | 8.36 Million USD | 29.74% |
| 2017 Q4 | -6.32 Million USD | -175.57% |
| 2016 Q4 | 8.7 Million USD | -6.68% |
| 2016 FY | 6.18 Million USD | -69.93% |
| 2016 Q3 | 9.32 Million USD | 154.82% |
| 2016 Q1 | 5.16 Million USD | -8.68% |
| 2016 Q2 | -17.01 Million USD | -429.45% |
| 2015 Q4 | 5.65 Million USD | -17.64% |
| 2015 Q3 | 6.86 Million USD | 58.88% |
| 2015 FY | 20.56 Million USD | 296.46% |
| 2015 Q1 | 3.72 Million USD | 141.92% |
| 2015 Q2 | 4.32 Million USD | 16.18% |
| 2014 Q1 | -1.49 Million USD | 79.03% |
| 2014 FY | -10.46 Million USD | -30.49% |
| 2014 Q4 | -8.87 Million USD | -603.35% |
| 2014 Q3 | 1.76 Million USD | 194.48% |
| 2014 Q2 | -1.86 Million USD | -25.15% |
| 2013 Q2 | -1.62 Million USD | -718.09% |
| 2013 Q3 | 914 Thousand USD | 156.14% |
| 2013 Q4 | -7.1 Million USD | -877.79% |
| 2013 FY | -8.02 Million USD | 67.28% |
| 2013 Q1 | -199 Thousand USD | 79.67% |
| 2012 Q2 | -20.26 Million USD | -53231.58% |
| 2012 Q3 | -23.59 Million USD | -16.42% |
| 2012 Q4 | -979 Thousand USD | 95.85% |
| 2012 Q1 | -38 Thousand USD | -101.4% |
| 2012 FY | -24.51 Million USD | -332.6% |
| 2011 Q4 | 2.72 Million USD | -34.47% |
| 2011 FY | 10.54 Million USD | 2703.46% |
| 2011 Q2 | 2.6 Million USD | 145.24% |
| 2011 Q1 | 1.06 Million USD | 112.72% |
| 2011 Q3 | 4.15 Million USD | 59.68% |
| 2010 Q4 | -8.34 Million USD | -383.89% |
| 2010 Q1 | 2.42 Million USD | 6.15% |
| 2010 Q2 | 3.35 Million USD | 38.55% |
| 2010 Q3 | 2.93 Million USD | -12.45% |
| 2010 FY | 376 Thousand USD | -97.88% |
| 2009 Q4 | 2.28 Million USD | -39.29% |
| 2009 FY | 17.7 Million USD | 108.85% |
| 2009 Q1 | 7.16 Million USD | 103.08% |
| 2009 Q2 | 4.49 Million USD | -37.21% |
| 2009 Q3 | 3.76 Million USD | -16.39% |
| 2008 Q4 | -232.49 Million USD | -2165.19% |
| 2008 FY | -200.07 Million USD | -576.15% |
| 2008 Q3 | 11.25 Million USD | 1.45% |
| 2008 Q2 | 11.09 Million USD | 10.21% |
| 2008 Q1 | 10.06 Million USD | -16.2% |
| 2007 Q2 | 9.3 Million USD | 11.83% |
| 2007 Q4 | 12.01 Million USD | -2.95% |
| 2007 Q1 | 8.32 Million USD | -33.6% |
| 2007 Q3 | 12.38 Million USD | 33.06% |
| 2007 FY | 42.01 Million USD | 49.13% |
| 2006 FY | 28.17 Million USD | -5.23% |
| 2006 Q4 | 12.53 Million USD | 2728.54% |
| 2006 Q1 | 7.66 Million USD | -22.81% |
| 2006 Q2 | 7.53 Million USD | -1.68% |
| 2006 Q3 | 443 Thousand USD | -94.12% |
| 2005 Q1 | 7.16 Million USD | -18.55% |
| 2005 FY | 29.73 Million USD | -18.68% |
| 2005 Q2 | 3.11 Million USD | -56.53% |
| 2005 Q3 | 9.51 Million USD | 205.42% |
| 2005 Q4 | 9.93 Million USD | 4.36% |
| 2004 FY | 36.56 Million USD | -23.8% |
| 2004 Q2 | 9.27 Million USD | 1.15% |
| 2004 Q3 | 9.31 Million USD | 0.46% |
| 2004 Q4 | 8.8 Million USD | -5.56% |
| 2004 Q1 | 9.17 Million USD | -15.46% |
| 2003 Q2 | 11.76 Million USD | -7.29% |
| 2003 Q3 | 12.67 Million USD | 7.66% |
| 2003 Q4 | 10.84 Million USD | -14.4% |
| 2003 FY | 47.98 Million USD | -18.22% |
| 2003 Q1 | 12.69 Million USD | -21.19% |
| 2002 Q2 | 14.75 Million USD | 11.93% |
| 2002 Q3 | 15.06 Million USD | 2.12% |
| 2002 Q1 | 13.18 Million USD | 5.08% |
| 2002 FY | 58.67 Million USD | 52.6% |
| 2002 Q4 | 16.1 Million USD | 6.9% |
| 2001 FY | 38.44 Million USD | 33.4% |
| 2001 Q2 | 111.35 Million USD | 0.0% |
| 2001 Q1 | 111.35 Million USD | 0.0% |
| 2001 Q3 | 11.32 Million USD | -89.83% |
| 2001 Q4 | 12.54 Million USD | 10.73% |
| 2000 FY | 28.82 Million USD | 63.26% |
| 1999 FY | 17.65 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 77.751% |
| Addus HomeCare Corporation | 90.95 Million USD | -23.92% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -1088.58% |
| Amedisys, Inc. | 156.39 Million USD | 27.93% |
| American Oncology Network, Inc. | -49.15 Million USD | 329.306% |
| Astrana Health, Inc. | 84.61 Million USD | -33.21% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -1296.345% |
| IMAC Holdings, Inc. | -6.37 Million USD | 1867.906% |
| biote Corp. | 28.65 Million USD | -293.318% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 1016.066% |
| COMPASS Pathways plc | -136.91 Million USD | 182.321% |
| DocGo Inc. | 15.05 Million USD | -648.676% |
| The Ensign Group, Inc. | 255.36 Million USD | 55.862% |
| Healthcare Services Group, Inc. | 62.35 Million USD | -80.751% |
| InnovAge Holding Corp. | -23.18 Million USD | 586.251% |
| Assure Holdings Corp. | -20.08 Million USD | 661.264% |
| The Joint Corp. | -2.07 Million USD | 5536.964% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 159.594% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 817.746% |
| ModivCare Inc. | -139.94 Million USD | 180.54% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -266726.855% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 1417.793% |
| Option Care Health, Inc. | 314.59 Million USD | 64.172% |
| P3 Health Partners Inc. | -167.86 Million USD | 167.147% |
| P3 Health Partners Inc. | -167.86 Million USD | 167.147% |
| The Pennant Group, Inc. | 25.16 Million USD | -347.825% |
| Surgery Partners, Inc. | 328 Million USD | 65.636% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 4003.347% |
| Talkspace, Inc. | -23.2 Million USD | 585.644% |
| Talkspace, Inc. | -23.2 Million USD | 585.644% |
| The Oncology Institute, Inc. | -77.01 Million USD | 246.346% |
| The Oncology Institute, Inc. | -77.01 Million USD | 246.346% |